Shiizaki K - Search Results

1

[Complications suffered by dialysis patients. 4. Hematologic problems].

Akizawa T, Shiizaki K. Akizawa T, et al. Among authors: shiizaki k. Nihon Naika Gakkai Zasshi. 2000 Jul 10;89(7):1366-71. Nihon Naika Gakkai Zasshi. 2000. PMID: 11032504 Review. Japanese. No abstract available.

2

Management of secondary hyperparathyroidism of dialysis patients.

Akizawa T, Kamimura M, Mizobuchi M, Shiizaki K, Sumikado S, Sakaguchi T, Negi S, Ogata H, Kinugasa E. Akizawa T, et al. Among authors: shiizaki k. Nephrology (Carlton). 2003 Oct;8 Suppl:S53-7. doi: 10.1046/j.1440-1797.8.s.9.x. Nephrology (Carlton). 2003. PMID: 15012693 Review.

3

[Low PTH level and adynamic bone disease in dialysis patients].

Shiizaki K, Sumikado S, Akizawa T. Shiizaki K, et al. Clin Calcium. 2004 Jan;14(1):16-20. Clin Calcium. 2004. PMID: 15576948 Review. Japanese.

4

Symptomatic bradycardia probably due to tizanidine hydrochloride in a chronic hemodialysis patient.

Kitabata Y, Orita H, Kamimura M, Shiizaki K, Narukawa N, Abe T, Kobata H, Akizawa T. Kitabata Y, et al. Among authors: shiizaki k. Ther Apher Dial. 2005 Feb;9(1):74-7. doi: 10.1111/j.1774-9987.2005.00206.x. Ther Apher Dial. 2005. PMID: 15828911

5

Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells.

Shiizaki K, Negi S, Hatamura I, Tatsuta K, Shibata M, Shimada S, Sakaguchi T, Akizawa T. Shiizaki K, et al. Kidney Int Suppl. 2006 Jul;(102):S12-5. doi: 10.1038/sj.ki.5001596. Kidney Int Suppl. 2006. PMID: 16810304 Free article.

6

Plasma exchange for the treatment of human T-cell lymphotropic virus type 1 associated myelopathy.

Narukawa N, Shiizaki K, Kitabata Y, Abe T, Kobata H, Akizawa T. Narukawa N, et al. Among authors: shiizaki k. Ther Apher. 2001 Dec;5(6):491-3. doi: 10.1046/j.1526-0968.2001.00398.x. Ther Apher. 2001. PMID: 11800087

7

Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.

Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Kunimoto K, Okamoto M, Imazeki I, Muragaki Y, Akizawa T. Shiizaki K, et al. Kidney Int. 2006 Aug;70(3):486-95. doi: 10.1038/sj.ki.5001564. Epub 2006 Jun 21. Kidney Int. 2006. PMID: 16788697 Free article.

8

Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients.

Shiizaki K, Negi S, Mizobuchi M, Hatamura I, Narukawa N, Sakaguchi T, Kitabata Y, Sumikado S, Akizawa T. Shiizaki K, et al. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii42-6. doi: 10.1093/ndt/gfg1011. Nephrol Dial Transplant. 2003. PMID: 12771299

9

[Enhanced expression of EGFR, TGF-alpha, EGF in hyperplastic parathyroid glands in established stage of renal failure in rats].

Orita H, Hatamura I, Saji F, Shibata M, Shiizaki K, Sakaguchi T, Negi S, Akizawa T. Orita H, et al. Among authors: shiizaki k. Clin Calcium. 2005 Sep;15 Suppl 1:60-63; discussion 63. Clin Calcium. 2005. PMID: 16411340 Japanese.

10

Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia.

Shiizaki K, Hatamura I, Negi S, Narukawa N, Mizobuchi M, Sakaguchi T, Ooshima A, Akizawa T. Shiizaki K, et al. Kidney Int. 2003 Sep;64(3):992-1003. doi: 10.1046/j.1523-1755.2003.00154.x. Kidney Int. 2003. PMID: 12911549 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters